Financial statements Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Exim
Balance sheet data of PRZEDSIĘBIORSTWO FARMACEUTYCZNE SULPHUR ZDRÓJ EXIM
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 3 495 687,69 | 3 254 514,86 | 3 068 516,39 | 3 943 312,16 | 4 761 376,61 |
A. Fixed assets | 1 980 903,51 | 1 752 046,39 | 1 533 665,53 | 1 321 270,90 | 1 178 013,17 |
B. Current assets | 1 514 784,18 | 1 502 468,47 | 1 534 850,86 | 2 622 041,26 | 3 583 363,44 |
C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | - | - |
D. Own shares (stocks) | - | 0,00 | 0,00 | - | - |
Total liabilities | 3 495 687,69 | 3 254 514,86 | 3 068 516,39 | 3 943 312,16 | 4 761 376,61 |
A. Equity | 2 532 992,94 | 2 564 395,13 | 2 370 560,23 | 3 108 455,46 | 3 709 257,42 |
B. Liabilities and provisions for liabilities | 962 694,75 | 690 119,73 | 697 956,16 | 834 856,70 | 1 052 119,19 |
I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 283 872,30 | 130 963,51 | 260 548,33 | 513 167,29 | 804 525,75 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.